EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

CAR-T Cell Therapy: From the Shop to Cancer Therapy

Ashanti Concepción Uscanga-Palomeque iD, Ana Karina Chávez-Escamilla, Cynthia Aracely Alvizo-Báez, Santiago Saavedra-Alonso, Luis Daniel Terrazas-Armendáriz, Reyes S Tamez-Guerra, Cristina Rodríguez-Padilla iD, Juan Manuel Alcocer-González iD

International Journal of Molecular Sciences · 28.10.2023 · 24 (21) · 15688

DOI: 10.3390/ijms242115688 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 28.10.2023. Verfasst von Ashanti Concepción Uscanga-Palomeque und 7 weiteren Autor:innen. Beteiligte Einrichtung: Laboratorio de Inmunología y Virología, Facultad de Ciencias Biológicas, Universidad Autónoma de Nuevo León, San Nicolás de los Garza 66450, Nuevo Le…. Hauptthemen laut MEDLINE: Receptors, Chimeric Antigen, Neoplasms. Die Arbeit wurde bisher 108-mal zitiert (Crossref) und nennt 118 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cancer is a worldwide health problem. Nevertheless, new technologies in the immunotherapy field have emerged. Chimeric antigen receptor (CAR) technology is a novel biological form to treat cancer; CAR-T cell genetic engineering has positively revolutionized cancer immunotherapy. In this paper, we review the latest developments in CAR-T in cancer treatment. We present the structure of the different generations and variants of CAR-T cells including TRUCK (T cells redirected for universal cytokine killing. We explain the approaches of the CAR-T cells manufactured ex vivo and in vivo. Moreover, we describe the limitations and areas of opportunity for this immunotherapy and the current challenges of treating hematological and solid cancer using CAR-T technology as well as its constraints and engineering approaches. We summarize other immune cells that have been using CAR technology, such as natural killer (NK), macrophages (M), and dendritic cells (DC). We conclude that CAR-T cells have the potential to treat not only cancer but other chronic diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptors, Chimeric AntigenNeoplasmsHumansImmunotherapy, AdoptiveT-LymphocytesCell- and Tissue-Based Therapy

Stichwörter der Autor:innen

CAR-TTRUCKcancer therapyimmunotherapyin vivo CAR-T

Substanzen

Receptors, Chimeric Antigen

Autor:innen und Institutionen

  • Laboratorio de Inmunología y Virología, Facultad de Ciencias Biológicas, Universidad Autónoma de Nuevo León, San Nicolás de los Garza 66450, Nuevo León, Mexico.

ORCID-Profile: Ashanti Concepción Uscanga-Palomeque, Cristina Rodríguez-Padilla, Juan Manuel Alcocer-González

Zitieren

APA

Uscanga-Palomeque, A. C., Chávez-Escamilla, A. K., Alvizo-Báez, C. A., Saavedra-Alonso, S., Terrazas-Armendáriz, L. D., Tamez-Guerra, R. S., Rodríguez-Padilla, C., & Alcocer-González, J. M. (2023). CAR-T Cell Therapy: From the Shop to Cancer Therapy. International Journal of Molecular Sciences, 24(21), 15688. https://doi.org/10.3390/ijms242115688

Vancouver

Uscanga-Palomeque AC, Chávez-Escamilla AK, Alvizo-Báez CA, Saavedra-Alonso S, Terrazas-Armendáriz LD, Tamez-Guerra RS, et al. CAR-T Cell Therapy: From the Shop to Cancer Therapy. International Journal of Molecular Sciences. 2023;24(21):15688. doi:10.3390/ijms242115688

BibTeX
@article{UscangaPalomeque2023,
  author = {Uscanga-Palomeque, Ashanti Concepción and Chávez-Escamilla, Ana Karina and Alvizo-Báez, Cynthia Aracely and Saavedra-Alonso, Santiago and Terrazas-Armendáriz, Luis Daniel and Tamez-Guerra, Reyes S and Rodríguez-Padilla, Cristina and Alcocer-González, Juan Manuel},
  title = {CAR-T Cell Therapy: From the Shop to Cancer Therapy},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  volume = {24},
  number = {21},
  pages = {15688},
  doi = {10.3390/ijms242115688}
}
Kostenlos starten →